Literature DB >> 14963289

MMP-9 polymorphisms are not associated with spontaneous cervical artery dissection.

Simone Wagner1, Britta Kluge, James A Koziol, Armin J Grau, Caspar Grond-Ginsbach.   

Abstract

BACKGROUND AND
PURPOSE: Cervical artery dissection (CAD) is a common cause of ischemic stroke in young adults. Alteration in the structure of the vascular extracellular matrix has been described in CAD. Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins and can lead to vascular damage.
METHODS: We tested 2 different MMP-9 DNA polymorphisms, a CA repeat and a cytosine to thymidine transition in the promotor sequence, for frequency in 52 patients with CAD. We compared the results with those of 52 healthy controls.
RESULTS: No differences were found in the allelic distribution of either polymorphism.
CONCLUSIONS: Alleles of these well-characterized functional polymorphisms of MMP-9 gene are not associated with structural alterations in the matrix of vessels of patients with CAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963289     DOI: 10.1161/01.STR.0000115754.20124.4F

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

2.  Traumatic vertebral artery injury: proposal for classification of the severity of trauma and likelihood of fatal outcome.

Authors:  Bela B Kubat; Marijke M Buiskool; Robert-Jan van Suylen
Journal:  Int J Legal Med       Date:  2014-10-14       Impact factor: 2.686

3.  Functional polymorphisms in matrix metalloproteinases -1, -3, -9 and -12 in relation to cervical artery dissection.

Authors:  Armin Buss; Katrin Pech; Susanne Roelver; Brunhilde Bloemeke; Christoph Klotzsch; Sebastian Breuer
Journal:  BMC Neurol       Date:  2009-08-09       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.